Loading stock data…
Alphatec Holdings (ATEC)
$9.51+0.21 (+2.26%)
Market OpenUpdated 2:04 PM EDT
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Alphatec Holdings, Inc. in the Healthcare sector is trading at $9.51 with a market capitalization of $1.3B. Wall Street consensus targets $16.73 (11 analysts), implying a +75.9% move over the next 12 months. The stock is currently near its 52-week low of $6.82, remaining 33.1% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 78 is overbought against a weak tape. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +75.9% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Overbought RSI 78 against a weak tape — risk of pullback
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $192.11M↓ | $212.93M↑ | $196.50M↑ | $185.54M↑ | $169.18M |
| Gross Profit | $136.48M↓ | $149.49M↑ | $137.30M↑ | $129.10M↑ | $116.00M |
| Operating Income | -$22.06M↓ | -$5.36M↑ | -$9.41M↑ | -$11.48M↑ | -$31.71M |
| Net Income | -$33.91M↓ | -$21.73M↑ | -$28.58M↑ | -$41.14M↑ | -$51.91M |
Peer Comparison
JNJUNHPFE
Fundamentals
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, ima...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.28B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
2344.44%
Volume
Today's trading volume
1.51M
Recent News
Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026?
Alphatec bets on integrated spine surgery tech, while Inspire leads in sleep apnea devices with robust profitability. How do their financials and risks stack up?
Here is Why Alphatec (ATEC) is One of the Best Cheap Stocks Under $10 to Buy in June
Alphatec Holdings Inc. (NASDAQ:ATEC) is one of the best cheap stocks under $10 to buy in June. On May 5, Alphatec Holdings reported Q1 2026 financial results, highlighted by a 17% increase in surgical revenue and 14% growth in total revenue to $192 million. The company achieved a non-GAAP adjusted EBITDA of $21 million, an […]
Alphatec Holdings, Inc. (ATEC): 12 Best Future Stocks to Buy Right Now.
With a five-year EPS forecast of 158.80%, Alphatec Holdings, Inc. (NASDAQ:ATEC) is among the 12 Best Future Stocks to Buy Right Now. On May 7, Barclays analyst Matt Miksic lowered the firm’s price target on Alphatec Holdings, Inc. (NASDAQ:ATEC) to $24 from $27 while maintaining an Overweight rating on the shares. Despite the lower target, Barclays kept […]
AppFolio And 2 Other High Growth Companies With Strong Insider Ownership
Over the last 7 days, the United States market has experienced a 1.0% drop, yet it remains up by 23% over the past year with earnings projected to grow by 17% annually. In this context, identifying growth companies with strong insider ownership can be an effective strategy as these firms often demonstrate commitment and confidence from those who know them best.
Alphatec Holdings (ATEC) Slid on Investors’ Reaction Towards Company and Sector Factors
Polen Capital, an investment management company, released its first-quarter 2025 investor letter for “Polen 5Perspectives Small Growth Strategy”. A copy of the letter is available to download here. Polen 5Perspectives Small Growth Composite Portfolio returned 3.3% gross and 3.0% net of fees, respectively, in the first quarter of 2026, compared to the -2.8% return of the […]